Merck seals $5.7bn biotech deal to boost cancer drug pipeline
Terns Pharma stock has jumped since promising clinical data on its bone and blood cancer treatment last year
Terns Pharma stock has jumped since promising clinical data on its bone and blood cancer treatment last year